Genes encoding art, an agouti-related transcript
| Title: | Genes encoding art, an agouti-related transcript |
|---|---|
| Patent Number: | 5,766,877 |
| Publication Date: | June 16, 1998 |
| Appl. No: | 08/757,541 |
| Application Filed: | November 27, 1996 |
| Abstract: | Disclosed is a novel gene termed ART which is expressed primarily in selected regions of the brain, as well as adrenal and lung tissues. Polypeptides encoded by ART are also disclosed, as are methods for preparing ART DNA and amino acid sequences. |
| Inventors: | Stark, Kevin Lee (Newbury Park, CA); Luethy, Roland (Newbury Park, CA) |
| Assignees: | Amgen Inc. (Thousand Oaks, CA) |
| Claim: | We claim |
| Claim: | 1. An isolated nucleic acid molecule, wherein the nucleic acid molecule is selected from the group consisting of |
| Claim: | (a) the nucleic acid molecule of SEQ ID NO:4; |
| Claim: | (b) the nucleic acid molecule of SEQ ID NO:5; |
| Claim: | (c) the nucleic acid molecule of SEQ ID NO:6; |
| Claim: | (d) the nucleic acid molecule of SEQ ID NO:9; |
| Claim: | (e) a nucleic acid molecule encoding the polypeptide of SEQ ID NO:8; |
| Claim: | (f) a nucleic acid molecule encoding the polypeptide of SEQ ID NO:10; |
| Claim: | (g) a nucleic acid molecule encoding the polypeptide of SEQ ID NO:11; and |
| Claim: | (h) a nucleic acid molecule that encodes a polypeptide that has at least 80 percent sequence identity with the polypeptides of SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:10, or SEQ ID NO:11. |
| Claim: | 2. A vector comprising the nucleic acid molecule of claim 1. |
| Claim: | 3. A host cell comprising the vector of claim 2. |
| Claim: | 4. A process for producing a biologically active ART (Agouti Related Transcript) polypeptide comprising the steps of |
| Claim: | (a) expressing a polypeptide encoded by a nucleic acid of claim 1 in a suitable host cell; and |
| Claim: | (b) isolating the polypeptide. |
| Claim: | 5. The process of claim 4 wherein the polypeptide is selected from the group consisting of: SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:10, and SEQ ID NO:11. |
| Claim: | 6. An isolated nucleic acid molecule that is the complement of the nucleic acid molecule of claim 1. |
| Claim: | 7. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:4. |
| Claim: | 8. A vector comprising the nucleic acid molecule of claim 7. |
| Claim: | 9. A host cell comprising the vector of claim 8. |
| Claim: | 10. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:5. |
| Claim: | 11. A vector comprising the nucleic acid molecule of claim 10. |
| Claim: | 12. A host cell comprising the vector of claim 11. |
| Claim: | 13. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:6. |
| Claim: | 14. A vector comprising the nucleic acid molecule of claim 13. |
| Claim: | 15. A host cell comprising the vector of claim 14. |
| Claim: | 16. An isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO:9. |
| Claim: | 17. A vector comprising the nucleic acid molecule of claim 16. |
| Claim: | 18. A host cell comprising the vector of claim 17. |
| Claim: | 19. An isolated nucleic acid molecule encoding the polypeptide of SEQ ID NO:7. |
| Claim: | 20. A vector comprising the nucleic acid molecule of claim 19. |
| Claim: | 21. A host cell comprising the vector of claim 20. |
| Claim: | 22. An isolated nucleic acid molecule encoding the polypeptide of SEQ ID NO:8. |
| Claim: | 23. An isolated nucleic acid molecule encoding the polypeptide of SEQ ID NO:10. |
| Claim: | 24. An isolated nucleic acid molecule encoding the polypeptide of SEQ ID NO:11. |
| Claim: | 25. A vector comprising the nucleic acid molecule of claim 24. |
| Claim: | 26. A host cell comprising the vector of claim 25. |
| Current U.S. Class: | 435/691; 536/235; 4352/523; 43525/411; 4353/201; 435/325 |
| Current International Class: | C12N 1512 |
| Patent References Cited: | 3773919 November 1973 Boswell et al. 5252714 October 1993 Harris et al. |
| Other References: | Shutter, et al, Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice, Genes & Development, 11: 593-602 (1997). A.G. Searle, Comparative Genetics of Coat Color in Mammals, Academic Press, New York, New York (1968), v-vii. Bultman et al., Molecular Characterization of the Mouse Agouti Locus, Cell, 71: 1195-1204 (1992). Takeuchi, Genetic Control of Signal Transduction in Mouse Melanocytes, Journal Invest. Dermatology, 92: 239S-242S (1989). Jackson, Color-Coded Switches, Nature, 362: 587-588 (1993). Lu et al., Agouti Protein is an Antagonist of the Melanocyte-stimulating Hormone Receptor, Nature, 371: 799-802 (1994). Willard et al., Agouti Structure and Function: Characterization of a Potent .alpha.-Melanocyte Stimulating Hormone Receptor Antagonist, Biochemistry, 34: 12341-12346 (1995). Wilson et al., Structure and Function of ASP, the Human Homolog of the Mouse Agouti Gene, Human Molecular Genetics, 4: 223-230 (1995). Kwon et al., Molecular Structure and Chromosomal Mapping of the Human Homolog of the Agouti Gene, Proc. Natl. Acad. Sci. USA, 91: 9760-9764 (1994). Manne et al., Mechanisms for the Pleiotropic Effects of the Agouti Gene, Proc. Natl. Acad. Sci. USA, 92: 4721-4724 (1995). Klebig et al., Ectopic Expression of the Agouti Gene in Transgenic Mice Causes Obesity, Features of Type II Diabetes, and Yellow Fur, Proc. Natl. Acad. Sci. USA, 92: 4728-4732 (1995). Ichida et al., Characteristics of Specific .sup.125 I-w-Conotoxin GVIA Binding in Rat Whole Brain, Neurochemial Research, 18: 1137-1144 (1993). Figueriedo et al., Purification and Amino Acid Sequence of the Insecticidal Neurotoxin T.times.4(6-1) from the Venom of the `Armed` Spider Phoneutria Nigriventer, Toxicon, 33: 83-93 (1995). Kim et al., Three-dimensional Solution Structure of the Calcium Channel Antagonist 2-Agatoxin IVA: Consenus Molecular Folding of Calcium Channel Blockers, Journal of Molecular Biology, 250: 659-671 (1995). Mountjoy et al., The Cloning of a Family of Genes That Encode the Melanocortin Receptors, Science, 257: 1248-1251 (1992). Roselli-Reyfuss et al., Identification of a Receptor for y melanotropin and Other Proopiomelanocortin Peptides in the Hypothalamus and Limbic System, Proc. Natl. Acad. Sci. USA, 90: 8856-8860 (1993). Labbe et al., Molecular Cloning of a Mouse Melanocortin 5 Receptor Gene Widely Expressed in Peripheral Tissues, Biochemistry, 33: 4543-4549 (1994). Qu et al., A Role for Melanin-concentrating hormone in the Central regulation of Feeding Behavior, Nature, 380: 243-247 (1996). Dayhoff et al., Atlas of Protein Sequence and Structure, 5, supp. 3, (1978), vii-xix. Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY (1989), xi-xxxvii. Ausubel et al. Current Protocols in Molecular Biology, Green Publishers Inc. & Wiley and Sons, NY (1994), iii-xi. Engels et al., Gene Synthesis, Angew. Chem. Intl. Ed., 28:716-734 (1989). Miller et al., An Insect Baculovirus Host-Vector System For High-Level Expression of Foreign Genes, Genetic Engineering, 8: 277-298 (1986). Ausubel et al., Current Protocols in Molecular Biology, Section 10.11.8, John Wiley and Sons, NY (1995), 10.11.8-10.11.22. Marston et al., Solubilization of Protein Aggregates, Meth. Enz, 182: 264-275 (1990). Merrifield, Solid Phase Peptide Synthesis, Journal of American Chemical Society, 85: 2149-2154 (1963). Houghten, General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids, Proc. Natl Acad. Sci. USA, 82: 5131, (1985). Stewart and Young, Solid Phase Peptide Synthesis, Pierce Chemical Co., Rockford, IL, 1984, vii-xi. Francis, protein modification and fusion proteins, Focus on Growth Factors 3: 4-10 (1992). Chamow et al., Modification of CD4 Immunoadhesin with Monomethoxyply (ehtylene glycol) Aldehyde via Reductive Alkylation, Bioconjugate Chem., 5: 133-140 (1994). Remington's, Pharmaceutical Sciences, 18th edition, A.R. Gennaro, ed., Mack Publishing Company (1990), xv-xvi. Sidman et al., Controlled release of macromolecules and pharmaceuticals form synthetic poly peptides based on glutamic acid, Biopolymers, 22: 547-556 (1983). Langer et al., Biocompatibility of polymeric delivery systems for macromolecules, J. Biomed. Mater. Res., 15: 167-277 (1981). Langer, Controlled release of macromolecules, Chem. Tech., 12: 98-105 (1982). Eppstein et al., Biological activity of liposome-encapsulated murine interferon .gamma. is mediated by a cell membrane receptor, Proc. Natl. Acad. Sci. USA, 82: 3688-3692 (1985). Hwang et al., Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol lipsomes: A kinetic study, Proc. Natl. Acad. Sci. USA, 77: 4030-4034 (1980). Gribskov et al., Profile Analysis: Detection of Distantly Related Proteins, Proc. Natl. Acad. Sci. USA, 84: 4355 (1987). Luethy et al., Improving the Sensitivity of the Sequence Profile Method, Protein Science, 3: 139-146 (1994). Hillier, L. et al. (Oct. 11, 1995) Washu-Merck EST Project. GenBank. EST-STS, EST-STS-Two, Accession No. H63735, Oct. 1995. Hiller, L. et al., (Oct. 11, 1995) Washu-Merck EST Project. GenBank. EST-STS, EST-STS-Two, Accession No. H63298, Oct. 1995. |
| Primary Examiner: | Ulm, John |
| Assistant Examiner: | Teng, Sally P. |
| Attorney, Agent or Firm: | Oleski, Nancy A. Levy, Ron K. Odre, Steven M. |
| Accession Number: | edspgr.05766877 |
| Database: | USPTO Patent Grants |
| Language: | English |
|---|